BenevolentAI Company
The Benevolent Platform™, including a biomedical knowledge graph and AI tools to generate novel hypotheses and identify drug targets.
Investors
Connections from
Industry:
Drug Repurposing
Headquarters:
United Kingdom
Total Funding:
> $300 M (pre-SPAC)
Founded Date:
2013